Dela Cruz, Arbie P.
HRN: 28-26-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2025
CEFUROXIME 1.5GM (VIAL)
12/12/2025
12/19/2025
IV
1.5g
Q8
None
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes .